Oyster Point Pharma

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OYST and other ETFs, options, and stocks.

About OYST

Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. 

CEO
Jeffrey A. Nau
CEOJeffrey A. Nau
Employees
62
Employees62
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
2015
Founded2015
Employees
62
Employees62

OYST Key Statistics

Market cap
299.05M
Market cap299.05M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
137.00K
Average volume137.00K
High today
$11.20
High today$11.20
Low today
$11.10
Low today$11.10
Open price
$11.12
Open price$11.12
Volume
122.57K
Volume122.57K
52 Week high
$19.98
52 Week high$19.98
52 Week low
$3.46
52 Week low$3.46

OYST Earnings

-$1.87
-$1.25
-$0.62
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, After Hours
ActualExpected Feb 23, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.